Marshall BioResources

What Marshall BioResources does

Marshall BioResources is a family-owned, privately held animal breeding company founded in 1939 and headquartered in North Rose, New York. The company specializes in the development, breeding, and supply of purpose-bred animal models for biomedical research, serving pharmaceutical, biotechnology, academic, and veterinary research institutions. Its core product portfolio comprises four proprietary lines: Marshall Beagle®, Marshall Ferret®, Marshall Cat®, and Gottingen Minipigs®, each maintained as genetically characterized colonies under controlled biosecurity conditions.

The company's underlying technology is biological rather than digital: decades of selective breeding have produced genetically stable, health-monitored animal lines with documented lineage. Operations are anchored by AAALAC International accreditation, a voluntary industry credential for humane treatment of animals in science, and ISO 9001:2015 certification covering global Marshall Beagle® facilities. These credentials are central to the company's value proposition, as research-grade animal supply is a regulated niche where buyers require validated, accredited sources.

Marshall BioResources generates revenue through direct sales of purpose-bred animals and related services to enterprise customers, primarily biomedical research institutions and secondarily veterinary pharmaceutical companies. Pricing is quote-based and not publicly disclosed. The company maintains animal colonies and operations in four countries — the United States, United Kingdom, France, and China — enabling global fulfillment. No third-party distribution channels are used; all customer engagement is direct. The company employs between 101 and 250 people and reports no external funding, acquisitions, or publicly disclosed financial metrics, consistent with its family-owned status.

Name

Marshall BioResources

Legal name

Marshall BioResources

Website

https://marshallbio.com

Company type

Private

Founded year

1939

Operating status

Operating

Headcount range

101–250 employees

Short description

Marshall BioResources is a family-owned supplier founded in 1939 that breeds purpose-bred animal models — beagles, ferrets, cats, and minipigs — for biomedical and veterinary pharmaceutical research institutions across the US, UK, France, and China.

Ownership category

akta.pro rank

Product category

Laboratory Animal Models

NAICS

Other Animal Production (1129)

SIC

Agricultural Prod-Livestock & Animal Specialties (200), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Companion/Specialty Animal Breeding & Genetics Services (non-livestock) (AFAEAJAO)

Keywords

• Laboratory animal models
• Biomedical research animals
• Purpose-bred beagles
• Research minipigs
• Preclinical research models

Headquarters

HQ city

North Rose

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Infrastructure, Supply Chain, Others

Distribution channels1 record

Marketing channels2 records

Core offering

Marshall BioResources breeds and supplies purpose-bred laboratory animals — Marshall Beagle®, Marshall Ferret®, Marshall Cat®, and Gottingen Minipigs® — for use in biomedical and veterinary pharmaceutical research. The animals are raised in AAALAC-accredited colonies located in the United States, United Kingdom, France, and China, with global Marshall Beagle® operations certified to ISO 9001:2015. The company sells directly to research institutions and pharmaceutical companies developing life-saving therapies, vaccines, and safety tests.

Product overview

Marshall BioResources is a family-owned animal breeding company (founded in 1939) that provides purpose-bred animal models for biomedical research. The company's core offerings include four branded animal species: Marshall Beagle®, Marshall Ferret®, Marshall Cat®, and Gottingen Minipigs®. These animals contribute to the development of life-saving therapies and treatments for both humans and pets. The company operates AAALAC-accredited facilities across multiple locations (US, UK, France, and China) with global Marshall Beagle® facilities certified to ISO 9001:2015 standard. Marshall BioResources primarily serves researchers in pharmaceutical, biotechnology, and veterinary medicine sectors.

Differentiator

Problem solved

Functional benefit

Brands

• Marshall Beagle®: Proprietary beagle breed used in biomedical research
• Marshall Ferret®
• Marshall Cat®
• Gottingen Minipigs®

Products and services

• Marshall Beagle® A purpose-bred beagle dog line used in biomedical research for developing life-saving therapies and treatments for humans and pets. Global Marshall Beagle® facilities are certified to the ISO 9001:2015 standard. Targeted at biomedical research institutions and veterinary pharmaceutical companies.
• Marshall Ferret® A ferret breed originally developed for hunting and later proven valuable for canine distemper vaccine development. Used in biomedical research for human and veterinary medicine.
• Marshall Cat® A purpose-bred cat line used in biomedical research, contributing to the development of life-saving therapies and treatments for humans and pets.
• Gottingen Minipigs® A minipig breed used in biomedical research for developing life-saving therapies and treatments, particularly valuable for translational research applications.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• Crown Bioscience: A global preclinical CRO with significant operations in China offering in-vivo efficacy services using proprietary animal models. Comparable in serving the same Asia-Pacific biopharma research customer base.
• Bionova Scientific: An emerging preclinical CRO focused on biologics and gene therapy safety assessment that consumes research animal models. Comparable as a downstream customer-segment competitor in specialized preclinical services.
• Cyagen Biosciences: An emerging supplier of genetically engineered rodent models and related research services with significant China operations. Comparable as a purpose-bred animal model supplier targeting pharmaceutical and academic customers in Asia.

Direct peers

• Jackson Laboratory: A nonprofit leading supplier of mouse models for biomedical research with global distribution. Comparable in providing genetically characterized research animals, though specialized in mice versus Marshall's larger species.
• Taconic Biosciences: A leading supplier of genetically engineered and standardized research rodent models. Comparable business model of providing purpose-bred animals to biomedical research customers, though focused on rodents rather than dogs, ferrets, cats, or pigs.
• Inotiv (Envigo): Through the Envigo acquisition, Inotiv supplies purpose-bred research animals (including beagles) and offers preclinical research services, directly competing with Marshall in the same customer segments.
• Charles River Laboratories: The largest global supplier of research animal models (including beagles and other species) and a full preclinical CRO. Directly comparable to Marshall in the research-models segment and overlapping in pharmaceutical and academic customer base.

Broad incumbents

• WuXi AppTec: A large global CRO/CDMO offering preclinical services including animal-based safety and efficacy studies. Comparable as a downstream buyer-adjacent service provider in the biomedical research value chain.
• Labcorp (Early Development): Through its Early Development and Covance segments, Labcorp offers preclinical safety and efficacy services that consume large volumes of research animals. Comparable as a buyer and competitor in the broader preclinical services ecosystem.

Regional players

• Trans Genic Inc. A Japanese supplier of genetically engineered and conventional research animal models, including contract breeding services. Comparable as a regional peer in the Asia-Pacific market with overlapping product offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Marshall BioResources